Dr. Max Rothwell

rothwell

Dr. Max Rothwell

Postdoctoral Neuroscientist

Max Rothwell graduated with a first-class M.Sci. degree in Neuroscience at the University of Nottingham in 2016. During his undergraduate studies, Max spent his third year working as a research student at Eli Lilly & Company (Lilly UK), where his research project involved both behavioural and electrophysiological experiments designed to elucidate pharmacodynamic biomarkers of drug action.

Max was awarded his D.Phil. at the University of Oxford in 2021. His thesis research in the Sharott Group was focused on investigating closed-loop adaptive Deep Brain Stimulation (aDBS) approaches for the treatment of Parkinsonism. Such strategies aim to improve upon current DBS therapies by selectively targeting ongoing pathological oscillations within the neuronal circuits of the basal ganglia.